Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/26 19:18 | 2/17/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Smith Julie | CA | D | 1 | S.dm | -4,687 | 44.00 | 0 | -107 | 21 | D | ||||||||||||||||
2/18/26 20:49 | 2/13/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Senner Christopher J. | CA | O | EVP,CFO | 1 | S.m | -2,811 | 43.32 | 0 | -65 | 979 | D | |||||||||||||||
2/18/26 20:49 | 2/17/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Haley Patrick J. | CA | O | EVP,Comm | 2 | S.m | -5,998 | 42.83 | 0 | -140 | 382 | D | |||||||||||||||
2/18/26 20:49 | 2/13/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Eckhardt Sue Gail | CA | D | 1 | S | -169 | 43.79 | 0 | -4 | 18 | D | ||||||||||||||||
2/18/26 20:48 | 2/13/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Oliver Bob | CA | D | 1 | S.d | -1,325 | 43.81 | 0 | -30 | 21 | D | ||||||||||||||||
2/18/26 20:48 | 2/18/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Hefti Brenda | CA | O | SVP,GC | 1 | S | -822 | 44.01 | 0 | -19 | 102 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |